These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 485685

  • 1. Autoradiographic evidence for passage of vincamine through the blood-brain barrier.
    Sprumont P, Lintermans J.
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):42-8. PubMed ID: 485685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Absorption, distribution and elimination of vincamine hydrochloride in the rat].
    Vigano V, Rognoni F, Piacenza G, Pesce E.
    Farmaco Prat; 1978 May; 33(5):224-31. PubMed ID: 744225
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L, Tamás J, Czira G, Szporny L.
    Arzneimittelforschung; 1980 May; 30(11):1860-5. PubMed ID: 7192994
    [Abstract] [Full Text] [Related]

  • 6. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)].
    Erking W, Lücker PW, Metz G, Specker M, Wetzelsberger K.
    Arzneimittelforschung; 1978 May; 28(12):2332-6. PubMed ID: 582951
    [Abstract] [Full Text] [Related]

  • 7. Studies on the vincamine-papaverine association. i. biochemical investigations.
    Costrini R, Galzigna L, Bianchi M, Nunziata A, Cattani L.
    Agressologie; 1978 May; 19(3):211-4. PubMed ID: 736220
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R, Saiz Vadillo MC, Molina IT, Cadórniga L.
    Int J Clin Pharmacol Res; 1984 May; 4(4):281-90. PubMed ID: 6500775
    [Abstract] [Full Text] [Related]

  • 9. [Kinetic behavior of 3H-vincamine in man. Compartmental analysis].
    Camón L, Rodríguez Farré E, Valdecasas FG.
    Arch Farmacol Toxicol; 1978 Apr; 4(1):39-40. PubMed ID: 697401
    [No Abstract] [Full Text] [Related]

  • 10. [Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
    Rolland A, Gibassier D, Chemtob C, Le Verge R.
    J Pharm Belg; 1984 Apr; 39(3):136-44. PubMed ID: 6481608
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H, Lamiable D, Houin G, Plat M, Choisy H, Tillement JP.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [Abstract] [Full Text] [Related]

  • 12. The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humans.
    Mayo BC, Biggs SR, Hawkins DR, Chasseaud LF, Darragh A, Baldock GA, Whitby BR.
    J Pharmacobiodyn; 1982 Dec; 5(12):951-64. PubMed ID: 7169608
    [No Abstract] [Full Text] [Related]

  • 13. Biopharmaceutic and pharmacokinetic aspects of vincamine HCl.
    Ritschel WA, Agrawala P.
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):129-36. PubMed ID: 4010386
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and metabolism of vincamine and related compounds.
    Vereczkey L.
    Eur J Drug Metab Pharmacokinet; 1985 Mar; 10(2):89-103. PubMed ID: 3899662
    [Abstract] [Full Text] [Related]

  • 15. [Biopharmaceutics of vincamine salts after oral administration in humans].
    Aiache JM, Turlier M, Sibaud Y.
    Farmaco Prat; 1985 Mar; 40(3):87-100. PubMed ID: 3996561
    [No Abstract] [Full Text] [Related]

  • 16. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
    Maincent P, Le Verge R, Sado P, Couvreur P, Devissaguet JP.
    J Pharm Sci; 1986 Oct; 75(10):955-8. PubMed ID: 3795026
    [Abstract] [Full Text] [Related]

  • 17. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N, Manna V, Agnoli A.
    Int J Clin Pharmacol Res; 1984 Oct; 4(4):291-302. PubMed ID: 6500776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A, D'Amore I.
    Int J Clin Pharmacol Res; 1984 Oct; 4(4):277-9. PubMed ID: 6500774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.